[KY] Subsidiary Signs Letter of Intent to Acquire Jade Pharmaceutical Co., Ltd.
Key facts
- [KY] Subsidiary Signs Letter of Intent to Acquire Jade Pharmaceutical Co., Ltd.
- KY's subsidiary, Chen Yao Medical Management Consulting Co., Ltd., has signed a letter of intent to acquire Jade Pharmaceutical Co., Ltd. for NT$25,000,000. The purpose is to expand domestic pharmacy sales channels and strengthen regional medical services.
- Source: TWSE
- Date: Mon Jun 15 2026 09:00:00 GMT+0900 (Japan Standard Time)
Direct answer
KY's subsidiary, Chen Yao Medical Management Consulting Co., Ltd., has signed a letter of intent to acquire Jade Pharmaceutical Co., Ltd. for NT$25,000,000. The purpose is to expand domestic pharmacy sales channels and strengthen regional medical services.
- Citation
- [KY] Subsidiary Signs Letter of Intent to Acquire Jade Pharmaceutical Co., Ltd. (Mon Jun 15 2026 09:00:00 GMT+0900 (Japan Standard Time)), TWSE
- Source
- TWSE
- Date
- Mon Jun 15 2026 09:00:00 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
KY's subsidiary, Chen Yao Medical Management Consulting Co., Ltd., has signed a letter of intent to acquire Jade Pharmaceutical Co., Ltd. for NT$25,000,000. The purpose is to expand domestic pharmacy sales channels and strengthen regional medical services.
AI Analysis
Frequently Asked Questions
- Q: Who is KY's subsidiary?
- A: It is Chen Yao Medical Management Consulting Co., Ltd.
- Q: Who is the acquisition target?
- A: It is Jade Pharmaceutical Co., Ltd.
- Q: How much is the acquisition amount?
- A: It is NT$25,000,000.
- Q: What is the purpose of the acquisition?
- A: To expand domestic pharmacy sales channels and strengthen regional medical services.
- Q: What is the plan after the acquisition?
- A: To retain the existing team of Jade Pharmaceutical Co., Ltd. and integrate the marketing and sales channels of both parties.